pubs.acs.org/joc
HIV protease inhibitors,3 factor XIa inhibitors4 and CB1
Two-Step Synthesis of Substituted 3-Aminoindazoles
from 2-Bromobenzonitriles
receptor inhibitors.5 Moreover, the 3-aminoindazoles have
been shown to be able to mimic the adenine nucleus of ATP
for the design of ATP-competitive receptor tyrosine kinase
inhibitors with potent antitumor activities.1d
Valerie Lefebvre, Thomas Cailly, Frederic Fabis,* and
Sylvain Rault
Due to their potential as valuable templates for medicinal
chemistry, considerable effort has recently been devoted to
the synthesis of substituted indazoles.6 In this context, the
synthesis of 3-aminoindazoles has attracted much attention.
Their synthesis typically involved an aromatic nucleophilic
substitution between hydrazine and o-substituted benzoni-
triles. The leaving group used for the reaction to succeed is
mainly fluorine1,7 but also more rarely chlorine8 or a nitro
group.9 3-Aminoindazoles substituted on the amino group
were prepared as well by reaction of hydrazine with N-
substituted fluoroarylthioamides.10 The main drawback of
these methods is the low yields and harsh conditions when o-
fluorobenzonitriles are deactivated by an electron-donating
group. Some alternative methods have been described such
as the Buchwald-Hartwig amination of 3-haloindazoles2,5
or the Pd-catalyzed intramolecular cyclization of tosylhy-
drazines;11 however, these latter methods need the prepara-
tion of the required starting material in several steps.
ꢀ
Centre d’Etudes et de Recherche sur le Medicament de
Normandie, UPRES EA 4258, INC3M FR-CNRS 3038,
ꢀ
UFR des Sciences Pharmaceutiques, Universite de Caen
Basse-Normandie, boulevard Becquerel 14032 Caen Cedex,
France
Received February 10, 2010
Transition-metal-catalyzed C-N bond formation has be-
come in the past decades one of the most valuable tools for
the synthesis of arylamines.12,13 Arylation of hydrazine
derivatives can be performed as well using either copper14
A general two-step synthesis of substituted 3-aminoinda-
zoles from 2-bromobenzonitriles involving a palladium-
catalyzed arylation of benzophenone hydrazone followed
by anacidicdeprotection/cyclization sequenceisdescribed.
This procedure offers a general and efficient alternative to
the typical SNAr reaction of hydrazine with o-fluoroben-
zonitriles.
(5) Santhakumar, V.; Tomaszewski, M. WO 2006/052190, May 18, 2006.
(6) For recent selected references, see: (a) Lebedev, A. Y.; Khartulyari,
A. S.; Voskboynikov, A. Z. J. Org. Chem. 2004, 70, 596. (b) Correa, A.;
Tellitu, I.; Dominguez, E.; SanMartin, R. Tetrahedron 2006, 62, 11100.
(c) Luklin, K.; Hsu, M. C.; Fernando, D.; Leanna, R. J. Org. Chem. 2006, 71,
8166. (d) Inamoto, K.; Katsuno, M.; Yoshino, T.; Arai, Y.; Hiroya, K.;
Sakamoto, T. Tetrahedron 2007, 63, 2695. (e) Vina, D.; del Olmo, D.; Lopez-
Perez, J. L.; San Feliciano, A. Org. Lett. 2007, 9, 525. (f) Inamoto, K.; Saito,
T.; Katsuno, M.; Sakamoto, T.; Hiroya, K. Org. Lett. 2007, 9, 2931.
(g) Crestey, F.; Stiebing, S.; Legay, R.; Collot, V.; Rault, S. Tetrahedron
2007, 63, 419. (h) Yanamoto, Y.; Jin, T. Angew. Chem., Int. Ed. 2007, 47,
3323. (i) Liu, Z.; Shi, F.; Raminelli, C.; Larock, R. C. J. Org. Chem. 2008, 73,
219. (j) Schmidt, A.; Beutler, A.; Snovydovych, B. Eur. J. Org. Chem. 2008,
4073. (k) Halland, N.; Nazare, M.; R’kyek, O.; Alonso, J.; Urmann, M.;
Lindenschmidt, A. Angew. Chem., Int. Ed. 2009, 48, 6879. (l) Crestey, F.;
Lohou, E.; Stiebing, S.; Collot, V.; Rault, S. Synlett 2009, 4, 615.
(7) Orsini, P.; Menichincheri, M.; Vanotti, E.; Panzeri, A. Tetrahedron
Lett. 2009, 50, 3098.
(8) Kruger, A. W.; Rozema, M. J.; Chu-Kung, A.; Gandarilla, J.; Haight,
A. R.; Kotecki, B. J.; Richter, S. M.; Schwartz, A. M.; Wang, Z. Org. Process
Res. Dev. 2009, 13, 1419.
(9) Candiani, I.; D’Arasmo, G.; Heidempergher, F.; Tomasi, A. Org.
Process Res. Dev. 2009, 13, 456.
(10) Burke, M. J.; Trantow, B. M. Tetrahedron Lett. 2008, 49, 4579.
(11) Suryakiran, N.; Prabhakar, P.; Venkateswarlu, Y. Chem. Lett. 2007,
36, 1370.
(12) For reviews on palladium-catalyzed C-N bond formation, see:
(a) Surry, D. S.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 6338.
(b) Beccalli, E. M.; Broggini, G.; Martinelli, M.; Sottocornola, S. Chem. Rev.
2007, 107, 5318. (c) Jiang, L.; Buchwald, S. L. In Metal-Catalyzed Cross-
Coupling Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH:
Weinheim, 2004.
The 3-aminoindazole scaffold is found in a great number
of compounds displaying a wide range of biological activities
including kinase inhibitors,1 MCH receptor 1 antagonists,2
(1) (a) Stocks, M.; Barber, S.; Ford, R.; Leroux, F.; St. Gallay, S.; Teague,
S.; Xue, Y. Bioorg. Med. Chem. Lett. 2005, 15, 3459. (b) Woods, K.; Fisher,
J.; Claiborne, A.; Li, T.; Thomas, S.; Zhu, G. D.; Diebold, R.; Liu, X.; Shi,
Y.; Klinghofer, V.; Han, E.; Guan, R.; Magnone, S.; Johnson, E.; Bouska, J.;
Olson, A.; de Jong, R.; Oltersdorf, T.; Luo, Y.; Rosenberg, S.; Giranda, V.;
Li, Q. Bioorg. Med. Chem. 2006, 14, 6832. (c) Dai, Y.; Hartandi, K.; Ji, Z.;
Ahmed, A. A.; Albert, D. H.; Bauch, J. L.; Bouska, J. J.; Bousquet, P. F.;
Cunha, G. A.; Glaser, K. B.; Harris, C. M.; Hickman, D.; Guo, J.; Li, J.;
Marcotte, P. A.; Marsh, K. C.; Moskey, M. D.; Martin, R. L.; Olson, A. M.;
Osterling, D. J.; Pease, L. J.; Soni, N. B.; Stewart, K. D.; Stoll, V. S.; Tapang,
P.; Reuter, D. R.; Davidsen, S. K.; Michaelides, M. R. J. Med. Chem. 2007,
50, 1584. (d) Lee, J.; Choi, H.; Kim, K. H.; Jeong, S.; Park, J. W.; Baeka,
C. S.; Lee, S. H. Bioorg. Med. Chem. Lett. 2008, 18, 2292. (e) Bauer, D.;
Whittington, D. A.; Coxon, A.; Bready, J.; Harriman, S. P.; Patel, V. F.;
Polverino, A.; Harmange, J. C. Bioorg. Med. Chem. Lett. 2008, 18, 4844.
(f) Antonysamy, S.; Hirst, G.; Park, F.; Sprengeler, P.; Stappenbeck, F.;
Steensma, R.; Wilson, M.; Wong, M. Bioorg. Med. Chem. Lett. 2009, 19, 279.
(2) Vasudevan, A.; Souers, A. J.; Freeman, J. C.; Verzal, M. K.; Gao, J.;
Mulhern, M. M.; Wodka, D.; Lynch, J. K.; Engstrom, K. M.; Wagaw, S. H.;
Brodjian, S.; Dayton, B.; Falls, D. H.; Bush, E.; Brune, M.; Shapiro, R. D.;
Marsh, K. C.; Hernandez, L. E.; Collins, C. A.; Kym, P. R. Bioorg. Med.
Chem. Lett. 2005, 15, 5293.
(13) For recent reviews on copper-catalyzed C-N bond formation, see:
(a) Monnier, F.; Taillefer, M. Angew. Chem., Int. Ed. 2009, 48, 6954. (b) Ma,
D.; Cai, Q. Acc. Chem. Res. 2008, 41, 1450. (c) Evano, G.; Blanchard, N.;
Toumi, T. Chem. Rev. 2008, 108, 3054.
(14) (a) Jiang, L.; Lu, X.; Zhang, H.; Jiang, Y.; Ma, D. J. Org. Chem.
2009, 74, 4542. (b) Lam, M. S.; Lee, H. W.; Chen, A. S. C.; Kwong, F. Y.
Tetrahedron Lett. 2008, 49, 6192. (c) Rao, H.; Jin, Y.; Fu, H.; Jiang, Y.; Zhao,
Y. Chem.;Eur. J. 2006, 12, 3636. (d) Wolter, M.; Klapars, A.; Buchwald,
S. L. Org. Lett. 2001, 3, 3803.
(3) Rodgers, J. D.; Lam, P. Y. S.; Johnson, B. L.; Wang, H.; Ko, S. S.;
Seitz, S. P.; Trainor, G. L.; Anderson, P. S.; Klabe, R. M.; Bacheler, L. T.;
Cordova, B.; Garber, S.; Reid, C.; Wright, M. R.; Chang, C. H.; Erickson-
Viitanen, S. Chem. Biol. 1998, 5, 597.
(4) Pinto, D. J. P.; Smallheer, J. M.; Corte, J. R.; Hu, Z.; Cavallaro, C. L.;
Gilligan, P. J.; Quan, M. L. WO 2007/070826, June 21, 2007.
2730 J. Org. Chem. 2010, 75, 2730–2732
Published on Web 03/17/2010
DOI: 10.1021/jo100243c
r
2010 American Chemical Society